QQ客服 官方微博 反馈留言

	Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2 V617F against myeloproliferative neoplasms
	Hu M.; Xu C.; Yang C.; Zuo H.; Chen C.; Zhang D.; Shi G.; Wang W.; 等 更多
刊名	Journal of Experimental and Clinical Cancer Research
	2019
卷号	38期号:1
关键词	Apoptosis JAK2 inhibitor JAK2 V617F Myeloproliferative neoplasms ZT55
DOI	10.1186/s13046-019-1062-x
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4531130
专题	山东大学
作者单位	State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science
推荐引用方式 GB/T 7714	Hu M.,Xu C.,Yang C.,et al. Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2 V617F against myeloproliferative neoplasms[J]. Journal of Experimental and Clinical Cancer Research,2019,38(1).
APA	Hu M..,Xu C..,Yang C..,Zuo H..,Chen C..,...&等 更多.(2019).Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2 V617F against myeloproliferative neoplasms.Journal of Experimental and Clinical Cancer Research,38(1).
MLA	Hu M.,et al."Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2 V617F against myeloproliferative neoplasms".Journal of Experimental and Clinical Cancer Research 38.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。